Fact CheckerSign in

NCT04219904Active, not recruitingEarly phase 1

PET/MRI Scan for the Evaluation of Resectable Stage IA1-IB3 Cervical Cancer

Evaluation of Resectable Cervical Carcinoma With PET/MRI

Source: ClinicalTrials.gov · Last updated 20 May 2026

Brief summary (registry, in English)

This trial studies how well positron emission tomography/magnetic resonance imaging (PET/MRI) scan works in checking patients with stage IA1-IB3 cervical cancer that can be removed by surgery (resectable). PET/MRI scan may help doctors learn more about the spread of the disease.

Status (registry)
Active, not recruiting
Phase (registry)
Early phase 1
Study type
Interventional
Enrollment
25 (estimated)
First submitted
30 Dec 2019
Start date
7 Sept 2018
Primary completion date
30 Sept 2027
Lead sponsor
M.D. Anderson Cancer Center
NCT number
NCT04219904

What you commit to

  • Study type: Interventional · Early phase 1
  • Planned participants: 25
  • From 7 Sept 2018 to the primary completion date, 30 Sept 2027
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Patients with history of previous radiation
  • Patients with previous surgery for cervical cancer, unless residual tumor noted on physical exam

Other illness

  • Patients with endometrial cancer extending to the cervix
  • Allergic reaction to gadolinium based contrast

Lab values

  • Glomerular filtration rate (GFR) \< 30

Other

  • Patients who have contraindication to MRI
  • Pregnant patients
  • Body weight of greater than 450 (181.4 kg)
  • Patients requiring general sedation
  • Extremely claustrophobic patients

Who the study is looking for

  • All patients with suspected clinical stage IA1-IB3 cervical cancer except patients with tumors \> 4 cm
  • No contraindications to MRI
  • Patients undergoing surgical procedure at MD Anderson
  • Suspected cervical cancer

Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
M D Anderson Cancer Center
Coordinator of this site? Confirm its status
HoustonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.